Advertisement
Screener

Immune Design Corp. Net Income (Loss) Available to Common Stockholders, Basic

Immune Design Corp. Net Income (Loss) Available to Common Stockholders, Basic

Immune Design Corp. reported Net Income (Loss) Available to Common Stockholders, Basic of -$13.60 million for the 3-month period ending 2018-12-31, per its 10-K filed 2019-03-13.

Discontinued › Income Statement › Net Income

us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic · last filed 2019-03-13

  • Immune Design Corp. net income (loss) available to common stockholders, basic for the quarter ending 2018-12-31 was -$13.60M.
  • Immune Design Corp. net income (loss) available to common stockholders, basic for the quarter ending 2018-09-30 was -$14.05M.
  • Immune Design Corp. net income (loss) available to common stockholders, basic for the quarter ending 2018-06-30 was -$13.81M.
  • Immune Design Corp. net income (loss) available to common stockholders, basic for the quarter ending 2018-03-31 was -$13.30M.
  • Immune Design Corp. net income (loss) available to common stockholders, basic for fiscal 2018 was -$54.76M.
  • Immune Design Corp. net income (loss) available to common stockholders, basic for fiscal 2017 was -$51.86M.
  • Immune Design Corp. net income (loss) available to common stockholders, basic for fiscal 2016 was -$53.53M.
  • Immune Design Corp. net income (loss) available to common stockholders, basic for fiscal 2015 was -$39.45M.
Period endNet Income (Loss) Available to Common Stockholders, Basic 3 monthNet Income (Loss) Available to Common Stockholders, Basic 6 monthNet Income (Loss) Available to Common Stockholders, Basic 9 monthNet Income (Loss) Available to Common Stockholders, Basic 12 month
2018-12-31-$13.60M
10-K · filed 2019-03-13
-$27.65M
derived: sum of 2 quarters · filed 2019-03-13
-$41.46M
derived: sum of 3 quarters · filed 2019-03-13
-$54.76M
10-K · filed 2019-03-13
2018-09-30-$14.05M
10-K · filed 2019-03-13
-$27.86M
derived: sum of 2 quarters · filed 2019-03-13
-$41.16M
10-Q · filed 2018-11-06
-$53.14M
derived: sum of 4 quarters · filed 2019-03-13
2018-06-30-$13.81M
10-K · filed 2019-03-13
-$27.11M
10-Q · filed 2018-08-01
-$39.09M
derived: sum of 3 quarters · filed 2019-03-13
-$52.50M
derived: sum of 4 quarters · filed 2019-03-13
2018-03-31-$13.30M
10-K · filed 2019-03-13
-$25.28M
derived: sum of 2 quarters · filed 2019-03-13
-$38.70M
derived: sum of 3 quarters · filed 2019-03-13
-$52.54M
derived: sum of 4 quarters · filed 2019-03-13
2017-12-31-$11.98M
10-K · filed 2019-03-13
-$25.40M
derived: sum of 2 quarters · filed 2019-03-13
-$39.24M
derived: sum of 3 quarters · filed 2019-03-13
-$51.86M
10-K · filed 2019-03-13
2017-09-30-$13.42M
10-K · filed 2019-03-13
-$27.26M
derived: sum of 2 quarters · filed 2019-03-13
-$39.88M
10-Q · filed 2018-11-06
-$54.33M
derived: sum of 4 quarters · filed 2019-03-13
2017-06-30-$13.85M
10-K · filed 2019-03-13
-$26.47M
10-Q · filed 2018-08-01
-$40.91M
derived: sum of 3 quarters · filed 2019-03-13
-$53.35M
derived: sum of 4 quarters · filed 2019-03-13
2017-03-31-$12.62M
10-K · filed 2019-03-13
-$27.07M
derived: sum of 2 quarters · filed 2019-03-13
-$39.51M
derived: sum of 3 quarters · filed 2019-03-13
-$53.86M
derived: sum of 4 quarters · filed 2019-03-13
2016-12-31-$14.45M
10-K · filed 2018-03-14
-$26.89M
derived: sum of 2 quarters · filed 2018-03-14
-$41.24M
derived: sum of 3 quarters · filed 2018-03-14
-$53.53M
10-K · filed 2019-03-13
2016-09-30-$12.44M
10-K · filed 2018-03-14
-$26.79M
derived: sum of 2 quarters · filed 2018-03-14
-$39.08M
10-Q · filed 2017-11-01
-$51.20M
derived: sum of 4 quarters · filed 2018-03-14
2016-06-30-$14.35M
10-K · filed 2018-03-14
-$26.64M
10-Q · filed 2017-08-02
-$38.76M
derived: sum of 3 quarters · filed 2018-03-14
-$46.16M
derived: sum of 4 quarters · filed 2018-03-14
2016-03-31-$12.29M
10-K · filed 2018-03-14
-$24.41M
derived: sum of 2 quarters · filed 2018-03-14
-$31.82M
derived: sum of 3 quarters · filed 2018-03-14
-$42.33M
derived: sum of 4 quarters · filed 2018-03-14
2015-12-31-$12.12M
10-K · filed 2017-03-07
-$19.52M
derived: sum of 2 quarters · filed 2017-03-07
-$30.04M
derived: sum of 3 quarters · filed 2017-03-07
-$39.45M
10-K · filed 2018-03-14
2015-09-30-$7.41M
10-K · filed 2017-03-07
-$17.92M
derived: sum of 2 quarters · filed 2017-03-07
-$27.33M
10-Q · filed 2016-11-09
-$40.45M
derived: sum of 4 quarters · filed 2017-03-07
2015-06-30-$10.52M
10-K · filed 2017-03-07
-$19.92M
10-Q · filed 2016-08-09
-$33.04M
derived: sum of 3 quarters · filed 2017-03-07
-$39.73M
derived: sum of 4 quarters · filed 2017-03-07
2015-03-31-$9.41M
10-K · filed 2017-03-07
-$22.53M
derived: sum of 2 quarters · filed 2017-03-07
-$29.21M
derived: sum of 3 quarters · filed 2017-03-07
-$35.33M
derived: sum of 4 quarters · filed 2017-03-07
2014-12-31-$13.12M
10-K · filed 2016-03-15
-$19.80M
derived: sum of 2 quarters · filed 2016-03-15
-$25.93M
derived: sum of 3 quarters · filed 2016-03-15
-$34.15M
10-K · filed 2017-03-07
2014-09-30-$6.68M
10-K · filed 2016-03-15
-$12.81M
derived: sum of 2 quarters · filed 2016-03-15
-$21.03M
10-Q · filed 2015-11-12
-$26.44M
derived: sum of 4 quarters · filed 2016-03-15
2014-06-30-$6.13M
10-K · filed 2016-03-15
-$14.35M
10-Q · filed 2015-08-12
-$19.75M
derived: sum of 3 quarters · filed 2016-03-15
-$23.75M
derived: sum of 4 quarters · filed 2016-03-15
2014-03-31-$8.22M
10-K · filed 2016-03-15
-$13.63M
derived: sum of 2 quarters · filed 2016-03-15
-$17.62M
derived: sum of 3 quarters · filed 2016-03-15
-$21.26M
derived: sum of 4 quarters · filed 2016-03-15
2013-12-31-$5.41M
10-K · filed 2015-03-31
-$9.40M
derived: sum of 2 quarters · filed 2015-03-31
-$13.03M
derived: sum of 3 quarters · filed 2015-03-31
-$15.97M
10-K · filed 2016-03-15
2013-09-30-$3.99M
10-K · filed 2015-03-31
-$7.63M
derived: sum of 2 quarters · filed 2015-03-31
-$10.57M
10-Q · filed 2014-11-13
2013-06-30-$3.63M
10-K · filed 2015-03-31
-$6.58M
10-Q · filed 2014-09-08
2013-03-31-$2.94M
10-K · filed 2015-03-31
2012-12-31-$10.84M
10-K · filed 2015-03-31